Benzenesulfonic acid, C10-13-alkyl derivs., sodium salts

Endpoint summary

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

A series of in vitro studies were conducted to assess the potential mutagenicity of LAS. In the first study (Schoeberl 1993), a bacterial mutagenicity study (Ames test) was conducted using S. typhimurium strains TA 1535, TA 1537, TA 98 and TA 100, as well as TA1538 at test concentrations of 8, 40, 200, 1000 and 5000 µg/plate. All strains tested negative with and without S9 activation.

In the second test (Anon. 1995), the potential of LAS to cause mutations in mammalian cells was examined. Chinese Hamster Ovary (CHO) cells were exposed to concentrations of 0, 0.6, 1, 1.8, 3, and 6 µg/ml without S9, and 0, 6, 10, 18, 30, and 60 µg/ml with S9. The cells were then examined for cytogenicity and mutation frequency. Ethyl methane sulfonate and 3-(20-)methylcholanthrene were used as positive control substances. Preliminary tests show the test substance was cytotoxic at concentrations of 50 µg/ml or greater with metabolic activation, and 100 µg/ml or above without metabolic activation. There was no biologically significant increase in mutation frequency in the treated groups. Therefore, results show that LAS was not mutagenic to CHO cells both in the presence and absence of S9.

The third study (Murie and Innes 1997) examined the potential of LAS to cause chromosomal aberrations in mammalian cells. Chinese hamster ovary cells were exposed to concentrations of 2.5, 5, 10, 15, 20, 26, 33, and 39 µg/ml with S9, and 20, 39, 58, 78, 104, 130, and 156 µg/ml without S9. No biologically significant results were seen in treated cultures in the absence of metabolic activation. In the presence of metabolic activation the results were more equivocal. In the first of three tests, no cytotoxicity, and no increase in chromosome aberrations were observed at doses of 10 or 20 μg/ml and 100% cytotoxicity was observed at 39 μg/ml. In the second test, a steep cytotoxicity curve was observed between 10 and 20 μg/ml with a cell count of 68/90 % at the 10 μg/ml dose and no living cells remaining at the 20 μg/ml dose. An increased in aberration frequency could be observed at the 10 μg/ml dose. No increase in aberration frequency has been observed at lower doses which also did no show any cytotoxicity. To gain clarity on the positive result an additional test was conducted. Here, no cytotoxicity and no increase in chromosomal aberration frequency have been observed at the 10 μg/ml dose. At the 15 μg/ml dose the cell number was reduced to 25 % which is why this dose group cannot be evaluated due to excessive cytotoxicity. These results indicate that LAS is weakly clastogenic at cytotoxic concentrations but negative at concentrations below cytotoxic concentrations in this in vitro assay.

Link to relevant study records

Reference

Reference 1

Endpoint:

in vitro gene mutation study in bacteria

Remarks:

Type of genotoxicity: gene mutation

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: GLP laboratory study

Justification for type of information:

The test substance is a constituent of the reference substance, with similar alkyl chain range. Although the test substance does not contain sodium ions, at physiological pH, the test substance forms the same species as the dossier substance.

Qualifier:

according to

Guideline:

EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)

Principles of method if other than guideline:

Directive 84/449/EEC, B.14 Mutagenicity (Salmonella typhimurium - reverse mutation assay)" 1984; equivalent to OECD 471

GLP compliance:

yes

Type of assay:

bacterial reverse mutation assay

Species / strain / cell type:

S. typhimurium TA 1535, TA 1537, TA 98 and TA 100

Details on mammalian cell type (if applicable):

also TA 1538

Metabolic activation:

with and without

Metabolic activation system:

Arochlor-induced S9 fraction

Test concentrations with justification for top dose:

8, 40, 200, 1000 and 5000 ug/plate

Vehicle / solvent:

Water solution at 50 g/L

Untreated negative controls:

yes

Negative solvent / vehicle controls:

yes

Remarks:

water

True negative controls:

yes

Positive controls:

yes

Remarks:

aminoanthracene

Positive control substance:

other: nitrofluorene, sodium azide and aminoacridine

Species / strain:

S. typhimurium TA 1535, TA 1537, TA 98 and TA 100

Metabolic activation:

with and without

Genotoxicity:

negative

Remarks:

with and without activation

Cytotoxicity / choice of top concentrations:

cytotoxicity

Vehicle controls validity:

valid

Untreated negative controls validity:

valid

Positive controls validity:

valid

Additional information on results:

TA 1538 also tested negative. During the pre-incubation test, signs of toxicity were noted at concentrations as low as 125 ug/plate. No precipitation of the product was observed at any concentration tested.

Conclusions:

LAS is not mutagenic in the Ames test.

Executive summary:

A bacterial mutagenicity study (Ames test) was conducted on LAS and was found to be negative for mutagenicity.

Reference 2

Endpoint:

in vitro gene mutation study in mammalian cells

Remarks:

Type of genotoxicity: gene mutation

Type of information:

experimental study

Adequacy of study:

key study

Study period:

May 16, 1995-June 30, 1995

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: Comparable to guideline study.

Qualifier:

equivalent or similar to

Guideline:

OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)

GLP compliance:

yes (incl. certificate)

Type of assay:

mammalian cell gene mutation assay

Species / strain / cell type:

Chinese hamster Ovary (CHO)

Metabolic activation:

with and without

Metabolic activation system:

S9 from aroclor 1254 induced rat liver

Test concentrations with justification for top dose:

0, 0.6, 1, 1.8, 3, 6 ug/ml without S9
0, 6, 10, 18, 30, 60 ug/ml with S9

Vehicle / solvent:

None

Untreated negative controls:

yes

Negative solvent / vehicle controls:

no

True negative controls:

yes

Remarks:

H0 medium

Positive controls:

yes

Positive control substance:

other: ethyl methane sulfonate; 3-(20-)methylcholanthrene

Details on test system and experimental conditions:

METHOD OF APPLICATION: in medium


DURATION
- Preincubation period: 1 week
- Exposure duration: 4 hrs
- Expression time (cells in growth medium): 6 days at 37 degree C for cloning efficiency study, 9 days for mutation assay


STAIN (for cytogenetic assays): Giemsa


NUMBER OF REPLICATIONS: 2

Evaluation criteria:

A test substance was considered mutagenic if a statistically significant dose-related increase in mutant frequency was found in concentrations with greater than 20% survival rate. The mean mutant frequency must also be significantly above the maximum spontaneous mutant frequency.

Statistics:

Statistical significance was determined by the t-test.

Species / strain:

Chinese hamster Ovary (CHO)

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

cytotoxicity

Remarks:

preliminary test showed cytotoxicity at >= 50 ug/ml without S9, and >= 100 ug/ml with S9.

Vehicle controls validity:

not examined

Untreated negative controls validity:

valid

Positive controls validity:

valid

Additional information on results:

COMPARISON WITH HISTORICAL CONTROL DATA: In both the studies with and without S9, the mutant frequencies in the treated groups were statistically significantly higher than in the concurrent negative controls. However, the mutant frequencies in the treated groups were not significantly increased when compared to historical negative controls. There was also no dose-response relationship. The increased mutant frequency in treated groups was therefore not considered to be biologically significant.

Remarks on result:

other: all strains/cell types tested

Results of Test 1 ¿ Without S9 Mix            

Concentration (ug/ml)	Absolute cloning efficiency (%)	Mutant frequency ( x 10^6)
0	82	3 ± 2
0.6	86	7 ± 1
1	85	3 ± 2
1.8	78	5 ± 2
3	86	1 ± 1
6	83	0 ± 1
EMS	83	277 ± 17

Results of Test 1 ¿ With S9 Mix     

Concentration (ug/ml)	Absolute cloning efficiency (%)	Mutant frequency ( x 10^6)
0	90	2 ± 1
6	88	1 ± 1
10	84	9 ± 4
18	78	5 ± 3
30	89	3 ± 2
60	89	7 ± 2
MCA	81	91 ± 9

Results of Test 2 ¿ Without S9 Mix

Concentration (ug/ml)	Absolute cloning efficiency (%)	Mutant frequency ( x 10^6)
0	96	1 ± 1
0.6	92	2 ± 3
1	95	1 ± 1
1.8	93	5 ± 2
3	90	2 ± 1
6	91	6 ± 6
EMS	90	309 ± 20

Results of Test 2 ¿ With S9 Mix     

Concentration (ug/ml)	Absolute cloning efficiency (%)	Mutant frequency ( x 10^6)
0	90	2 ± 1
6	92	7 ± 3
10	88	9 ± 2
18	94	2 ± 1
30	93	2 ± 2
60	90	5 ± 1
MCA	95	89 ± 6

Conclusions:

Interpretation of results:
negative

The test substance is not mutagenic in either the presence or absence of metabolic activation.

Executive summary:

This study examined the potential of the test substance to cause mutations in mammalian cells. Chinese Hamster Ovary (CHO) cells were exposed to concentrations of 0, 0.6, 1, 1.8, 3, and 6 ug/ml without S9, and 0, 6, 10, 18, 30, and 60 ug/ml with S9. The cells were then examined for cytogenicity and mutation frequency. Ethyl methane sulfonate and 3-(20-)methylcholanthrene were used as positive control substances. Preliminary tests show the test substance was cytogenic at concentrations of 50 ug/ml or greater with metabolic activation, and 100 ug/ml or above without metabolic activation. There was no biologically significant increase in mutation frequency in the treated groups. The test substance is considered not mutagenic to CHO cells both in the presence and absence of S9.

Reference 3

Endpoint:

in vitro cytogenicity / chromosome aberration study in mammalian cells

Remarks:

Type of genotoxicity: chromosome aberration

Type of information:

experimental study

Adequacy of study:

key study

Study period:

May 25, 1995-November 23, 1995

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: GLP study done according to OECD guidelines. However, this study does not adequately address the results obtained at mildly cytotoxic concentrations.

Qualifier:

according to

Guideline:

OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)

GLP compliance:

yes (incl. certificate)

Type of assay:

in vitro mammalian chromosome aberration test

Species / strain / cell type:

Chinese hamster Ovary (CHO)

Metabolic activation:

with and without

Metabolic activation system:

S9 from Aroclor 1254 induced rat liver

Test concentrations with justification for top dose:

All concentrations in micrograms/ml

Test 1 with S9: 0.32, 0.63, 1.25, 2.5, 5, 10, 20, 39, 78
Test 1 without S9: 1.25, 2.5, 5, 10, 20, 39, 58,78, 156

Test 2 with S9: 2.5, 5, 10, 20, 26, 33, 39
Test 2 without S9: 20, 39, 58, 78, 130, 156

An additional test was done with S9 at the following dose levels:
2.5, 5, 7.5, 10, 15, 20, 25, and 30 ug/ml

Vehicle / solvent:

None

Untreated negative controls:

yes

Negative solvent / vehicle controls:

no

True negative controls:

no

Positive controls:

yes

Positive control substance:

other: methyl methanesulphonate, cyclophosphamide

Details on test system and experimental conditions:

METHOD OF APPLICATION: in medium


DURATION
- Exposure duration: 6 hrs with S9, 22 hrs without S9
- Expression time (cells in growth medium): 16-40 hrs with S9, 40 hrs without S9
- Selection time (if incubation with a selection agent): 2 hrs
- Fixation time (start of exposure up to fixation or harvest of cells): 24-48 hrs


SELECTION AGENT (mutation assays): Colcemid

NUMBER OF REPLICATIONS: 3


NUMBER OF CELLS EVALUATED: 100 metaphases


DETERMINATION OF CYTOTOXICITY
- Method: number of cells per culture


OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes

Evaluation criteria:

A dosage was considered toxic if cell count was less then 60% of cell cultures. A test substance was considered clastogenic if a single dose caused the percentage of aberrant cells to be consistently greater than the 99% confidence limits of negative controls and there was also an increase at another dose level.

Statistics:

95% and 99% confidence limits

Species / strain:

Chinese hamster Ovary (CHO)

Metabolic activation:

with and without

Genotoxicity:

positive

Cytotoxicity / choice of top concentrations:

cytotoxicity

Remarks:

>= 15 microgram/ml with S9, >=58 microgram/ml without S9

Vehicle controls validity:

not examined

Untreated negative controls validity:

valid

Positive controls validity:

valid

Additional information on results:

In the absence of S9, only one culture (Test 2, 24 hr harvest, 20 ug/ml) showed a suspicious result. This single result was considered sporadic, as other cultures at this concentration, or at higher concentrations did not show a positive response. In Test 1, in the absence of S9, cytoxicity was seen at 78 micrograms/ml and above. In Test 2, in the absence of S9, cytoxicity was seen at concentrations of 58 micrograms/ml and above.

In Test 1, in the presence of S9, no positive results were seen at concentrations of up to 20 micrograms/ml. Metaphases could not be analyzed due to severe cytotoxicity at the 39 and 78 microgram/ml concentrations. In Test 2, in the presence of S9, one of the cultures at the 5 microgram/ml concentration gave a suspicious result, and both cultures at the 10 microgram/ml concentrations gave positive responses. Mild cytotoxity was also seen at the 10 microgram/ml concentration. At concentrations at and above 20 micrograms/ml, metaphases could not be analyzed due to severe cytotoxicity. No positive results were seen in the Test 2, 48 hr harvest cultures grown in the presence of S9, though moderate cytotoxicity was seen in one of the 20 microgram/ml cultures, and severe cytotoxicity was seen in all cultures above this concentration.

A third test was done in the presence of S9, which showed positive results at the 15 micrograms/ml concentration. However, this concentration was also moderately cytotoxic with only 26% of cells survival. However, due to the low survival of cells, these results are not definitive for determining clastogenicity. Higher concentrations were completely cytotoxic. An additional assessment was then performed at 10 micrograms/ml in the presence of S9, with negative results.

Remarks on result:

other: all strains/cell types tested

Abbreviations used in tables:

T- Toxicity evident from morphological changes

TT- Toxicity evident from reduced cell count (<60% of vehicle)

TTT- Too toxic for metaphase assessment

Concentration (micrograms/ml)	Aberration Frequency (lesions/cell)	Aberrant Cell Frequency (% Including Gaps)	Aberrant Cell Frequency (% Excluding Gaps)	Cytotoxicity
Ham's F10 medium	0.01	1	0	Nil
Ham's F10 medium	0.02	1	1	Nil
0.32	-	-	-	Nil
0.32	-	-	-	Nil
0.63	-	-	-	Nil
0.63	-	-	-	Nil
1.25	-	-	-	Nil
1.25	-	-	-	Nil
2.5	0.01	1	0	Nil
2.5	0.00	0	0	Nil
5	0.00	0	0	Nil
5	0.05	5	0	Nil
10	0.01	1	0	Nil
10	0.01	1	0	Nil
20	0.00	0	0	Nil
20	0.00	0	0	Nil
39	-	-	-	TTT
39	-	-	-	TTT
78	-	-	-	TTT
78	-	-	-	TTT
Cyclophosphamide (20 micrograms/ml)	0.14	8	4	-
Cyclophosphamide (30 micrograms/ml)	0.06	4	4	-
Cyclophosphamide (40 micrograms/ml)	0.33	20	19	-

Test 1 ¿ Without S9 Mix, 24 hr Harvest

Concentration (micrograms/ml)	Aberration Frequency (lesions/cell)	Aberrant Cell Frequency (% Including Gaps)	Aberrant Cell Frequency (% Excluding Gaps)	Cytotoxicity
Ham¿s F10 medium	0.00	0	0	Nil
Ham¿s F10 medium	0.00	0	0	Nil
1.25	-	-	-	Nil
1.25	-	-	-	Nil
2.5	-	-	-	Nil
2.5	-	-	-	Nil
5	-	-	-	Nil
5	-	-	-	Nil
10	-	-	-	Nil
10	-	-	-	Nil
20	-	-	-	Nil
20	-	-	-	Nil
39	0.01	1	0	Nil
39	0.00	0	0	Nil
58	0.01	1	0	Nil
58	0.00	0	0	Nil
78	0.00	0	0	T
78	0.00	0	0	T
156	-	-	-	TTT
156	-	-	-	TTT
Methyl methane-sulphonate (10 micrograms/ml)	0.03	3	1	-
Cyclophosphamide (20 micrograms/ml)	0.16	14	10	-

Test 2 ¿ With S9 Mix, 24 hr Harvest

Concentration (micrograms/ml)	Aberration Frequency (lesions/cell)	Aberrant Cell Frequency (% Including Gaps)	Aberrant Cell Frequency (% Excluding Gaps)	Cytotoxicity
Ham¿s F-10 medium	0.01	1	0	Nil
Ham¿s F-10 medium	0.02	2	1	Nil
2.5	0.07	2	1	Nil
2.5	0.04	3	1	Nil
5	0.04	3	2	Nil
5	0.06	6	4	Nil
10	0.12	8	6	T
10	0.19	13	5	T
20	-	-	-	TTT
20	-	-	-	TTT
26	-	-	-	TTT
26	-	-	-	TTT
33	-	-	-	TTT
33	-	-	-	TTT
39	-	-	-	TTT
39	-	-	-	TTT
Cyclophosphamide (40 micrograms/ml)	0.38	20	17	-
Cyclophosphamide (50 micrograms/ml)	0.31	18	11	-

Test 2 ¿ With S9 Mix, 48 hr Harvest

Concentration (micrograms/ml)	Aberration Frequency (lesions/cell)	Aberrant Cell Frequency (% Including Gaps)	Aberrant Cell Frequency (% Excluding Gaps)	Cytotoxicity
Ham¿s F-10 medium	0.00	0	0	Nil
Ham¿s F-10 medium	0.00	0	0	Nil
2.5	0.01	1	0	Nil
2.5	0.01	1	1	Nil
5	0.00	0	0	Nil
5	0.02	2	2	Nil
10	0.03	2	1	Nil
10	0.02	2	1	TT
20	-	-	-	TTT
20	-	-	-	TTT
26	-	-	-	TTT
26	-	-	-	TTT
33	-	-	-	TTT
33	-	-	-	TTT
39	-	-	-	TTT
39	-	-	-	TTT
Cyclophosphamide (40 micrograms/ml)	0.03	3	2	-
Cyclophosphamide (50 micrograms/ml)	0.10	8	7	-

Test 2 ¿ Without S9 Mix, 24 hr Harvest

Concentration (micrograms/ml)	Aberration Frequency (lesions/cell)	Aberrant Cell Frequency (% Including Gaps)	Aberrant Cell Frequency (% Excluding Gaps)	Cytotoxicity
Ham¿s F-10 medium	0.02	2	2	Nil
Ham¿s F-10 medium	0.03	3	0	Nil
20	0.02	2	0	Nil
20	0.05	5	3	Nil
39	0.02	2	1	Nil
39	0.04	4	0	Nil
58	0.01	1	1	Nil
58	0.06	6	1	Nil
78	-	-	-	TTT
78	-	-	-	TTT
104	-	-	-	TTT
104	-	-	-	TTT
130	-	-	-	TTT
130	-	-	-	TTT
156	-	-	-	TTT
156	-	-	-	TTT
Methyl methane-sulphonate (10 micrograms/ml)	0.30	21	14	-
Methyl methane-sulphonate (20 micrograms/ml)	0.71	33	28	-

Test 2 ¿ Without S9 Mix, 48 hr Harvest

Concentration (micrograms/ml)	Aberration Frequency (lesions/cell)	Aberrant Cell Frequency (% Including Gaps)	Aberrant Cell Frequency (% Excluding Gaps)	Cytotoxicity
Ham¿s F-10 medium	0.01	1	1	Nil
Ham¿s F-10 medium	0.00	0	0	Nil
20	0.00	0	0	Nil
20	0.00	0	0	Nil
39	0.01	1	1	Nil
39	0.00	0	0	Nil
58	0.00	0	0	T
58	0.01	1	0	T
78	-	-	-	TTT
78	-	-	-	TTT
104	-	-	-	TTT
104	-	-	-	TTT
130	-	-	-	TTT
130	-	-	-	TTT
156	-	-	-	TTT
156	-	-	-	TTT
Methyl methane-sulphonate (20 micrograms/ml)	0.21	11	8	-
Methyl methane- sulphonate (40 micrograms/ml)	3.20	60	60	-

Test 3 ¿ With S9 Mix, 24 hr Harvest

Concentration (micrograms/ml)	Aberration Frequency (lesions/cell)	Aberrant Cell Frequency (% Including Gaps)	Aberrant Cell Frequency (% Excluding Gaps)	Cytoxicity
Ham¿s F-10 medium	0.04	4	0	Nil
Ham¿s F-10 medium	0.04	4	0	Nil
2.5	-	-	-	Nil
2.5	-	-	-	Nil
5	-	-	-	Nil
5	-	-	-	Nil
7.5	-	-	-	Nil
7.5	-	-	-	Nil
10	-	-	-	Nil
10	-	-	-	Nil
15	0.20	12	8	TT
15	0.18	12	6	TT
20	-	-	-	TTT
20	-	-	-	TTT
25	-	-	-	TTT
25	-	-	-	TTT
30	-	-	-	TTT
30	-	-	-	TTT
Cyclophosphamide (30 micrograms/ml)	0.24	14	12	-
Cyclophosphamide (40 micrograms/ml)	0.32	17	11	-

Test 3 - see tables below

Conclusions:

Interpretation of results:
negative without metabolic activation
positive with metabolic activation at cytotoxic concentrations or above

The test substance is not clastogenic in the absence of metabolic activation. The test substance is also not clastogenic in the presence of metabolic activation at non-cytotoxic concentrations. At cytotoxic concentrations, the test substance is weakly clastogenic.

Executive summary:

This study examined the potential of the test substance Marlon A 350 to cause chromosomal aberrations in mammalian cells. Chinese hamster ovary cells were exposed to concentrations of 0.32 to 78 ug/ml with S9, and 1.25 to 156 ug/ml without S9. Methyl methanesuflphonate and cyclophosphamide were used as positive controls. No biologically significant results were seen in treated cultures in the absence of metabolic activation. Positive responses were seen at cytotoxic concentrations in the presence of S9. Concentrations below the level of cytotoxicty with S9 did not show positive results. The test substance is not clastogenic in the absence of metabolic activation, or with metabolic activation below cytotoxic concentrations. These results indicate that LAS is weakly clastogenic at cytotoxic concentrations but negative at concentrations below cytotoxic concentrations

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (negative)

Genetic toxicity in vivo

Description of key information

A robust in vivo mammalian micronucleus study is available on the structurally related substance LAS Acid (CAS#85536-14-7, Benzenesulfonic acid, C10-13-sec alkyl derivatives). In this study (Fedtke 1991), 40 male and 40 female mice were given a single oral dose by gavage of 1122 mg/kg LAS Acid (read across) and evaluated for chromosome aberrations. Only a single dose has been evaluated which was in the range of the acute oral LD50 value for LAS Acid in rats (LD50 = 1470 mg/kg). Furthermore, slight cytotoxicity has been observed after 48 hours. No statistically significant or biologically relevant increases in the number of polychromatic erythrocytes with micronuclei were observed; therefore the test material is considered negative for cytogenicity.

In an in vivo mammalian chromosome aberration study on LAS by Inoue et al. 1976, groups of male mice were given doses of 200, 400, or 800 mg/kg of LAS. This is about half the acute oral LD50 of 1655 mg/kg, as cited by the authors of the study. Mice were sacrificed at 6, 24, and 48 hrs, three of the mice from each dosage group were sacrificed, and bone marrow cells from the femurs collected and examined for chromosome aberrations. In addition, one group of mice was exposed daily for 5 consecutive days. Additional groups of mice were exposed to commercial detergents containing 19% or 17.1% of LAS. None of the treatment groups showed any significant increase in chromosome aberrations as compared to negative controls while the positive control, Mitomycin C, clearly showed an increase in chromosomal aberration frequency. Therefore, LAS was not considered clastogenic in this assay.

A second chromosomal aberration study was conducted by Masubuchi et al. 1976. In this study, groups of five male mice or five male rats were fed diets containing 0.9% LAS for 9 months (1125 mg/kg bw/d for mice, 405 mg/kg bw/d for rats). At the end of this period, the animals were sacrificed, and the bone marrow cells examined for chromosome aberrations. No increase in chromosome aberrations was seen as compared to negative controls in either species but no positive controls have been included in this assay. LAS was not clastogenic in this assay.

These same authors (Masubuchi et al. 1976) also conducted a dominant lethal study in mice. A group of seven male mice were fed a diet containing 0.6% LAS for 9 months (750 mg/kg bw/d). At the end of this period they were each mated with two untreated females. Females were sacrificed on day 13 of gestation for examination of ovaries and uteri. No evidence of dominant lethal mutations was observed as compared to the controls.

Link to relevant study records

Reference

Reference 1

Endpoint:

in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus

Remarks:

Type of genotoxicity: chromosome aberration

Type of information:

read-across based on grouping of substances (category approach)

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: GLP laboratory study

Qualifier:

equivalent or similar to

Guideline:

OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)

GLP compliance:

yes (incl. certificate)

Type of assay:

micronucleus assay

Species:

mouse

Strain:

NMRI

Sex:

male/female

Details on test animals and environmental conditions:

Strain NMRI. Animals were approximately 22-26 g (male) and 20-25 g (female) and acclimated for 1 week to the test conditions (20 =/- 3 degrees C, 30-70% relative humidity, 12 hour light/dark cycle). Food was given daily and water was ad libitum. All animals were healthy at the time of test initiation.

Route of administration:

oral: gavage

Vehicle:

NaCl

Duration of treatment / exposure:

72 hours

Frequency of treatment:

single dose

Remarks:

Doses / Concentrations:
1122 mg/kg
Basis:
actual ingested

No. of animals per sex per dose:

40 males and 40 females per dose

Control animals:

yes

Positive control(s):

Endoxan (cyclophosphamid)

Tissues and cell types examined:

Cells were taken from the thigh.

Details of tissue and slide preparation:

Cells were mixed with cattle serum and suspended, then centrifuged. The sediment was then resuspended. The suspension was seperated in a cellulose chromatography column. This was centrifuged, and mixed with fetal calf serum and EDTA. This was air-dried for 24 hrs and stained with Giemsa.

Evaluation criteria:

number of polychromatid erythrocytes (PCE)
ratio of PCE to normochromatid erythrocytes (NCE)
number of cells with micronucleus

Sex:

male/female

Genotoxicity:

negative

Toxicity:

no effects

Vehicle controls validity:

valid

Negative controls validity:

valid

Positive controls validity:

valid

No significant increases in the number of polychromatic erythrocytes with micronuclei were observed.

Conclusions:

Interpretation of results: negative

Executive summary:

No significant increases in the number of polychromatic erythrocytes with micronuclei were observed.

Reference 2

Endpoint:

in vivo mammalian germ cell study: cytogenicity / chromosome aberration

Remarks:

Type of genotoxicity: chromosome aberration

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: Well-documented publication.

Qualifier:

no guideline followed

Principles of method if other than guideline:

Groups of male mice were given doses of 200, 400, or 800 mg/kg of Benzenesulfonic acid, C10-14-alkyl derivs., sodium salts. At 6, 24, and 48 hrs, 3 of the mice from each dosage group were sacrificed. The bone marrow cells from the femurs were collected and examined for chromosome aberrations. In addition, one group of mice was exposed daily for 5 consecutive days. Additional groups of mice were exposed to commerical detergents containing 19% or 17.1% of the test substance. Mitomycin C was used as a positive control.

GLP compliance:

no

Type of assay:

chromosome aberration assay

Species:

mouse

Strain:

other: ICR/JCL

Sex:

male

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: CLEA Japan Inc.
- Age at study initiation: 9-11 weeks
- Housing: individually in plastic cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): tap water ad libitum

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 +/- 2
- Humidity (%): 55 +/- 5
- Photoperiod (hrs dark / hrs light): 12/12 hrs

Route of administration:

oral: gavage

Vehicle:

- Vehicle(s)/solvent(s) used: distilled water

Details on exposure:

PREPARATION OF DOSING SOLUTIONS: Samples were diluted to make a 5 ml/kg dose volume

Duration of treatment / exposure:

Single treatment, except for one group which was given 5 consecutive daily exposures to the test substance

Frequency of treatment:

once daily

Remarks:

Doses / Concentrations:
200, 400, 800 mg/kg
Basis:
nominal conc.
test substance

Remarks:

Doses / Concentrations:
800, 1600, 3200 mg/kg
Basis:
nominal conc.
commercial detergent containing 19% test substance

Remarks:

Doses / Concentrations:
1000, 2000, 4000 mg/kg
Basis:
nominal conc.
commercial detergent containing 17.1% test substance

No. of animals per sex per dose:

9

Control animals:

yes, concurrent vehicle

Positive control(s):

mitomycin C1

- Route of administration: intraperitoneally
- Doses / concentrations: 5 mg/kg

Tissues and cell types examined:

bone marrow cells from femurs

Details of tissue and slide preparation:

CRITERIA FOR DOSE SELECTION:

TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): 3 animals were sacrificed at 6, 24, and 48 hrs after treatment. One group was exposed daily for 5 days prior to sacrifice.

DETAILS OF SLIDE PREPARATION: Cells were placed in Hank's solution, then centrifuged at 1000 rpm for 5 min. Supernatant was discarded, and 5 ml of 0.075 M KCl was added. The mixture then stood for 5 min., then was stirred and centrifuged again. This was repeated several times, before finally placing one or two drops on the slides, and staining with 2% Giemsa solution.

Evaluation criteria:

number of cells with chromatid and chromosome gaps, number of cells with aberrations
50 metaphases per animal (150 total) were imaged at each time point.

Sex:

male

Genotoxicity:

negative

Toxicity:

not examined

Vehicle controls validity:

valid

Negative controls validity:

valid

Positive controls validity:

valid

Additional information on results:

No significant differences in the incidence of chromosomal aberrations were observed in any test substance treatment group relative to the controls.

Chromosome Aberrations

	Total number of cells having aberrations and occurrence (%)
	6 hrs	24 hrs	48 hrs	5 days
200 mg/kg	0 (0)	0 (0)	0 (0)	1 (0.7)
400 mg/kg	1 (0.7)	0 (0)	0 (0)	0 (0)
800 mg/kg	0 (0)	0 (0)	0 (0)	0 (0)
800 mg/kg of 17.1% detergent	0 (0)	0 (0)	0 (0)	-
1600 mg/kg of 17.1% detergent	0 (0)	1 (0.7)	0 (0)	-
3200 mg/kg of 17.1% detergent	2 (1.3)	2 (1.3)	0 (0)	-
1000 mg/kg of 19% detergent	-	0 (0)	-	-
2000 mg/kg of 19% detergent	-	0 (0)	-	-
4000 mg/kg of 19% detergent	-	0 (0)	-	-
Mitomycin C	16 (10.7)	53 (353)	13 (8.7)	112 (74.7)
Distilled water	0 (0)	0 (0)	0 (0)	0 (0)
untreated	0 (0)	0 (0)	1 (0.7)	0 (0)

Conclusions:

Interpretation of results: negative
The test substance is not clastogenic.

Executive summary:

Groups of male mice were given doses of 200, 400, or 800 mg/kg of Benzenesulfonic acid, C10-14-alkyl derivs., sodium salts. At 6, 24, and 48 hrs, 3 of the mice from each dosage group were sacrificed. The bone marrow cells from the femurs were collected and examined for chromosome aberrations. In addition, one group of mice was exposed daily for 5 consecutive days. Additional groups of mice were exposed to commerical detergents containing 19% or 17.1% of the test substance. Mitomycin C was used as a positive control. None of the treatment groups showed any significant increase in chromosome aberrations as compared to negative controls. The test substance in not clastogenic.

Reference 3

Endpoint:

in vivo mammalian germ cell study: cytogenicity / chromosome aberration

Remarks:

Type of genotoxicity: chromosome aberration

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: Well-documented journal article.

Qualifier:

no guideline followed

Principles of method if other than guideline:

A group of 5 male mice was fed a diet containing 0.9% test substance for 9 months. At the end of this period, the animals were sacrificed, and the bone marrow cells examined for chromosome aberrations.

GLP compliance:

no

Type of assay:

mammalian germ cell cytogenetic assay

Species:

mouse

Strain:

other: JCL-ICR

Sex:

male

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: CLEA Japan, Inc.
- Age at study initiation: 4 weeks
- Housing: individually, except during breeding
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period:

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 25 +/- 1
- Humidity (%): 55 +/- 5
- Photoperiod (hrs dark / hrs light): 12/12

Route of administration:

oral: feed

Details on exposure:

DIET PREPARATION
- Mixing appropriate amounts with (Type of food): feed powder CE-2

Duration of treatment / exposure:

9 months

Frequency of treatment:

daily

Remarks:

Doses / Concentrations:
0.9%, 1170 mg/kg bw d
Basis:
nominal in diet

No. of animals per sex per dose:

5

Control animals:

yes

Tissues and cell types examined:

femur bone marrow cells

Details of tissue and slide preparation:

Animals were sacrificed by administration of 1 ml/kg of 1% colchine solution. Femurs were then removed, and bone marrow cells washed into centrifuge tubes. The cells were then treated with 0.075 M KCl solution at 37 degree C for 15 min, and then fixed with an acetic acid 1: ethanol 3 solution. Samples were then flame dried and treated with Giemsa.

Evaluation criteria:

Presence and absence of chromosomal aberrations. 50 metaphases per individual.

Statistics:

Rohrborn's method.

Sex:

male

Genotoxicity:

negative

Negative controls validity:

valid

Additional information on results:

No increase in chromosome aberrations was noted.

Chromosome Aberrations

	0.9% in Diet	Control
No. of cells with chromatid breaks	1	2
No. of cells with isochromatid breaks	1	0
No. of cells with chromatid gaps	4	5
No. of cells with isochromatid gaps	0	0
No. of cells with other aberrations	0	0

Conclusions:

Interpretation of results: negative
The test substance is not clastogenic.

Executive summary:

A group of 5 male mice was fed a diet containing 0.9% test substance for 9 months. At the end of this period, the animals were sacrificed, and the bone marrow cells examined for chromosome aberrations. No increase in chromosome aberrations was seen as compared to controls. The test substance is not clastogenic.

Reference 4

Endpoint:

in vivo mammalian germ cell study: cytogenicity / chromosome aberration

Remarks:

Type of genotoxicity: chromosome aberration

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: Well-documented journal article.

Qualifier:

no guideline followed

Principles of method if other than guideline:

Groups of 5 male rats were fed a diet containing 0.9% test substance for 9 months. At the end of this period, the animals were sacrificed, and the bone marrow cells examined for chromosome aberrations.

GLP compliance:

no

Type of assay:

mammalian germ cell cytogenetic assay

Species:

rat

Strain:

other: Wistar and SD

Sex:

male

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: CLEA Japan, Inc.
- Age at study initiation: 4 weeks
- Housing: individually
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period:

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 25 +/- 1
- Humidity (%): 55 +/- 5
- Photoperiod (hrs dark / hrs light): 12/12

Route of administration:

oral: feed

Details on exposure:

DIET PREPARATION
- Mixing appropriate amounts with (Type of food): feed powder CE-2

Duration of treatment / exposure:

9 months

Frequency of treatment:

daily

Remarks:

Doses / Concentrations:
0.9%, 450 mg/kg bw d
Basis:
nominal in diet

No. of animals per sex per dose:

10

Control animals:

yes

Tissues and cell types examined:

femur bone marrow cells

Details of tissue and slide preparation:

Animals were sacrificed by administration of 1 ml/kg of 1% colchine solution. Femurs were then removed, and bone marrow cells washed into centrifuge tubes. The cells were then treated with 0.075 M KCl solution at 37 degree C for 15 min, and then fixed with an acetic acid 1: ethanol 3 solution. Samples were then flame dried and treated with Giemsa.

Evaluation criteria:

Presence and absence of chromosomal aberrations. 50 metaphases per individual.

Statistics:

Rohrborn's method.

Sex:

male

Genotoxicity:

negative

Negative controls validity:

valid

Additional information on results:

No increase in chromosome aberrations was noted.

Chromosome Aberrations

	0.9% in Diet ¿ Wister Rats	0.9% in Diet ¿ SD Rats	Control	Control
No. of cells with chromatid breaks	0	0	1	0
No. of cells with isochromatid breaks	0	0	0	0
No. of cells with chromatid gaps	3	4	3	4
No. of cells with isochromatid gaps	0	0	0	0
No. of cells with other aberrations	0	0	0	0

Conclusions:

Interpretation of results: negative
The test substance is not clastogenic.

Executive summary:

Groups of 5 male rats were fed a diet containing 0.9% test substance for 9 months. At the end of this period, the animals were sacrificed, and the bone marrow cells examined for chromosome aberrations. No increase in chromosome aberrations was seen as compared to controls. The test substance is not clastogenic.

Reference 5

Endpoint:

in vivo mammalian germ cell study: cytogenicity / chromosome aberration

Remarks:

Type of genotoxicity: chromosome aberration

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: Well-documented journal article.

Qualifier:

no guideline followed

Principles of method if other than guideline:

A group of 7 male mice was fed a diet containing 0.6% test substance for 9 months. At the end of this period, the animals were each mated with two untreated females. On day 13 of pregnancy, the females were sacrificed, and the ovaries and uteri were examined.

GLP compliance:

no

Type of assay:

rodent dominant lethal assay

Species:

mouse

Strain:

other: JCL-ICR

Sex:

male

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: CLEA Japan, Inc.
- Age at study initiation: 4 weeks
- Housing: individually, except during breeding
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 25 +/- 1
- Humidity (%): 55 +/- 5
- Photoperiod (hrs dark / hrs light): 12/12

Route of administration:

oral: feed

Details on exposure:

DIET PREPARATION
- Mixing appropriate amounts with (Type of food): feed powder CE-2

Duration of treatment / exposure:

9 months

Frequency of treatment:

daily

Remarks:

Doses / Concentrations:
0.6%, 780 mg/kg bw d
Basis:
nominal in diet

No. of animals per sex per dose:

7

Control animals:

yes

Statistics:

Rohrborn's method.

Sex:

male

Genotoxicity:

negative

Negative controls validity:

valid

Additional information on results:

There were no significant differences in fertility, the mortality of ova and embryos, the number of surviving fetuses, or the index of dominant lethal induction between the experimental groups and the control group.

Dominant Lethal Assay Results

	0.6% in Diet	Control
Number of mating females	14	18
Number pregnant	11	12
No. with dead embryos	6	10
Dead embryos per pregnant female	54.6%	83.3%
No. of corpora lutea	156	161
Corpora lutea per pregnant female	14.2	13.4
No. of implants	148	156
Implants per pregnant female	13.5	13.0
Implants per corpora lutea	94.9	96.9
No. of live fetuses	142	143
Live fetuses per pregnant female	12.9	11.9
Live fetuses per corpora lutea	91.0	88.8
Live fetuses per total implants	96.0	91.7
No. of early dead fetuses	4	12
No. of late dead fetuses	2	1
% of dominant lethals	-4.67	-
% of dominant lethals	-8.33	-

Conclusions:

Interpretation of results: negative
The test substance did not cause genetic disorders in mice.

Executive summary:

A group of 7 male mice was fed a diet containing 0.6% test substance for 9 months. At the end of this period, the animals were each mated with two untreated females. On day 13 of pregnancy, the females were sacrificed, and the ovaries and uteri were examined. No increase in dominant lethal induction was seen as compared to controls. The test substance does not cause genetic disorders.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (negative)

Additional information

LAS was consistently found not to cause induction of gene mutations in the Ames bacterial reverse mutation assay as well as in the OECD 476 in vitro mammalian cell gene mutation test. LAS was found to be positive at cytotoxic concentrations with metabolic activation, but negative at non-cytotoxic concentrations with metabolic activation and negative without metabolic activation, when tested in an in vitro chromosome aberration assay in CHO cells. When tested in a battery of in vivo genotoxicity studies, LAS was consistently found not to cause any mutagenic or clastogenic responses. An additional study conducted on the structural analogue LAS Acid further supports that LAS is not expected to be mutagenic or clastogenic. The positive result in the in vitro chromosome aberration study using a rodent cell line (CHO cells) derived from cancer tissues that is lacking proper cell cycle control has to be seen in the context of the extensive in vivo data. In vivo studies do assess genotoxicity under more realistic conditions, including eADME and metabolic activation.

Justification for selection of genetic toxicity endpoint
In vivo experimental studies, consistent with in vitro mutagenicity studies, considered more reliable than in vitro cytogenic study.

Justification for classification or non-classification

Based on the consistent absence of mutagenic or clastogenic responses in in vivo studies using LAS or the structural analogue LAS Acid, LAS is not expected to be mutagenic or clastogenic.